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Clinical Significance of Amniotic Fluid Debris in Cervical 
Cerclage Patients 
Nicole O. Afuape, Heather H. Love, Michael M. Plevyak (in memorium), Vida V. Rastegar, Corina N. Schoen 
BACKGROUND 
• Preterm delivery is delivery between 20 and 37 weeks of 
gestation; the prevalence of prematurity is approximately 12% 
among US births, only 50% of which can be associated with 
preterm labor.  
 
• Short cervical length (cervical length less than 25mm before 24-
28 weeks) independently increases in the risk of preterm birth.  
 
•The presence of amniotic fluid sludge on antenatal ultrasound 
has also been identified as a potential independent risk factor for 
spontaneous preterm delivery 
  
 •No significant association between the presence of amniotic 
fluid debris and preterm delivery. Previously published studies 
have reflected mixed results.  
 
•There were significant trends towards delivery at earlier 
gestational age and lower birth weight for neonates with amniotic 
fluid debris documented. 
 
•No difference in chorioamnionitis or neonatal sepsis in the two 
study groups.  
•  
•Limitations of this study include small sample size and 
retrospective design.  
 
•Despite the lack of association identified in this study, this 
investigation adds to the data that can be used to counsel 
cerclage candidates and shape expectations. 
 
This is a retrospective cohort study including women with a 
singleton pregnancy who underwent a transvaginal cerclage for 
ultrasound or physical exam indications between January 2001 
and December 2016 at Baystate Medical Center.  
 
Key Inclusion Criteria: 
• Cerclage placement prior to 24 weeks gestation  
• Ultrasound imaging prior to cerclage placement for 
determination of presence or absence of amniotic debris 
•Complete/ accessible clinical records 
 
Primary Outcome: Preterm delivery less than 37 weeks. 
 
Secondary Outcomes: Mode of delivery, 5 minute Apgar <7, 
birthweight, chorioamnionitis, preterm premature rupture of 
membranes (PPROM) and defined adverse neonatal outcomes 
METHODS 
CONCLUSION 
UMMS-Baystate Research & Education:  Together we advance the state of caring through discovery & innovation 
RESULTS 
•There was no difference in the rate of preterm delivery <37 
weeks, regardless of presence of amniotic debris. 
 
•Data analysis also lacked any difference in second trimester 
loss. 
 
 
 
  
 
Table 1. Pregnancy Outcomes 
Sludge (Total N = 98) 
Yes (N=70) No (N=28) p value 
PTB <37 weeks 16 (57) 38 (54) 0.8 
Chorioamnionitis 4 (14.3) 3 (4.5) 0.1 
Mean GA at Delivery 
(weeks) 
31 (7.8) 34 (6.1) 0.05 
Birthweight (SD) 1973 (1248) 2532 (1021) 0.03 
Data presented as n(%) or mean (SD) 
•A total of 354 transvaginal cerclage patients were identified 
during the study period with 98 meeting inclusion criteria. 
 
•There was no difference in progesterone use or prior preterm 
birth history for women with or without debris. 
 
•Women with amniotic fluid debris were found to generally have 
a shorter pre-cerclage cervical length (8 vs 15 mm, p<.001) 
 
•Women with amniotic fluid debris were also more likely to have 
visible membranes at time of cerclage (53.8% v. 26.2% p=0.015). 
 
 
  
 
OBJECTIVE 
Table 2. Neonatal Outcomes 
Sludge (Total N = 98) 
Yes (N=70) No (N=28) p value 
5 minute Apgar <7 8 (32) 11(16.7) 0.1 
NICU Admission 8 (32) 23 (35) 1.0 
NICU Length of Stay (SD) 54.38 (40.64) 37.53 (37.08) 0.2 
Neonatal Sepsis 3 (12) 5 (7.4) 0.4 
Baby Expired 6 (23.1) 5 (7.6) 0.06 
Data presented as n(%) or mean (SD) 
RESULTS 
To investigate for an association between amniotic fluid debris 
and preterm delivery in singleton pregnancies managed with 
ultrasound or physical exam indicated transvaginal cerclage. 
  
 
•There were no differences in PPROM, chorioamnionitis,  or 
neonatal secondary outcomes. 
 
 
 
  
 
Do Trophectoderm Biopsies Affect Pregnancy and Neonatal 
Outcomes Following Cryopreserved Single Embryo Transfer? 
Sophia Bachilova MD, Lisa Ashcraft, Tayyab Rahil PhD, Vida Rastegar MPH, Cynthia Sites MD 
BACKGROUND 
METHODS 
• Single-center retrospective cohort of singleton pregnancies 
delivered after 20 weeks gestation at Baystate Medical Center 
resulting from transfer of cryopreserved-warmed embryos 
between January 1, 2013 and  May 31, 2018 
• Inclusion: all singleton deliveries following frozen embryo  
transfer with or without trophectoderm biopsy  
• Exclusion: Donor egg, gestational carrier 
• Primary outcome: Rate of preeclampsia 
• Secondary outcomes: Rates of preterm delivery, low birth 
weight, still birth 
• Means, medians, and percentages were compared using 
Student’s t-test for continuous variables, Kruskal-Wallis test 
for non-parametric variables, and Fisher’s exact test for 
percentages.  
CONCLUSION 
Rates of preeclampsia and adverse neonatal 
outcomes do not appear to be affected by 
trophectoderm biopsy.  To see a twofold 
increase in pre-eclampsia rates (8% vs 16%) at 
80% power would require  a sample size of 500 
patients.   
UMMS-Baystate Research & Education:  Together we advance the state of caring through discovery & innovation 
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• Preimplantation genetic testing is used to select  euploid and 
unaffected embryos. 
• Following trophectoderm biopsy, blastocysts are 
cryopreserved while awaiting biopsy results for frozen embryo 
transfer in subsequent cycles.  
• We hypothesize that removing tropectoderm cells may  affect 
maternal and neonatal outcomes. 
RESULTS 
• 198 pregnancies : 19 biopsied, 179 not biopsied embryos 
• Baseline variables were similar (Table 1). 
• Rates of preeclampsia and preterm delivery were 2-fold higher 
following trophectoderm biopsy vs. no biopsy, but not 
statistically increased  (Figure 1 and Table 2). 
• Rates of low  birth weight and still born were small and similar 
between biopsy  vs. no biopsy groups (Table 2). 
  No biopsy Biopsy   
  (N = 179) (N = 19) p-value 
 Age (Q1, Q3) 33.0 (31.0, 37.0) 34.0 (33.0, 38.0) 0.24 
 Maternal pre-pregnancy BMI 25.7 (22.5, 31.3) 25.1 (23.8, 31.3) 0.97 
 Gestational age at delivery 39.0 (38.0, 40.0) 39.0 (39.0, 40.0) 0.98 
 Maternal race/ethnicity 0.28 
      White 156 (87.2%) 17 (89.5%) 
      Asian 4 (2.2%) 0 (0.0%) 
      Black/African American 4 (2.2%) 2 (10.5%) 
      Hispanic 11 (6.1%) 0 (0.0%) 
      Other 4 (2.2%) 0 (0.0%) 
 Nulliparity 102 (57.0%) 11 (57.9%) >0.99 
 History of preterm delivery 13 (7.3%) 2 (10.5%) 0.64 
 History of SGA infant 1 (0.6%) 1 (5.3%) 0.19 
 Pre-gestational diabetes  4 (2.2%) 1 (5.3%) 0.40 
 Pre-gestational hypertension 10 (5.6%) 2 (10.5%) 0.32 
 Maternal smoking 20 (11.2%) 1 (5.3%) 0.76 
Table1.   Baseline demographics 
  No biopsy Biopsy   
  (N = 179) (N = 19) p-value 
Preeclampsia     0.39 
      No 164 (91.6%) 16 (84.2%)   
      Yes 15 (8.4%) 3 (15.8%)   
Birth status      >0.99 
      Live born 177 (98.9%) 19 (100.0%)   
      still born 2 (1.1%) 0 (0.0%)   
Preterm delivery     0.39 
      >=37 weeks 164 (91.6%) 16 (84.2%)   
      <37 weeks 15 (8.4%) 3 (15.8%)   
Low Birth Weight     >0.99 
      >=2500g 170 (95.0%) 19 (100.0%)   
      <2500 9 (5.0%) 0 (0.0%)   
Table 2.  Outcomes for biopsied and not-biopsied embryos 
0%
4%
8%
12%
16%
20%
No Biopsy Biopsy
Figure 1.  Rate of preeclampsia  
Preparing Ob/Gyn Residents for the Fundamentals of  
Laparoscopic Surgery (FLS) Assessment 
Nicole O. Afuape, MD, Donald E. Kirton, MD, Heather Z. Sankey, MD 
University of Massachusetts Medical School- Baystate 
INTRODUCTION 
The purpose of this report is to describe the 
training curriculum that has been successful in 
preparing Obstetrics & Gynecology residents 
for Fundamentals of Laparoscopic Surgery 
(FLS) certification at the University of 
Massachusetts Medical School (UMMS)-
Baystate campus. 
UMMS-Baystate Research & Education:  Together we advance the state of caring through discovery & innovation 
METHODS RESULTS CONCLUSION 
BACKGROUND 
In January of 2018, the American Board of 
Obstetrics & Gynecology (ABOG) announced 
the plan to make FLS certification a 
requirement for board certification in 
Obstetrics and Gynecology. There are few 
published works focused on FLS 
implementation into Ob/Gyn education. FLS 
certification during resident training was first 
offered to UMMS-Baystate Ob/Gyn residents 
in 2011. After this initial trial, FLS certification 
was made mandatory for graduation by the 
2012 academic year.  
 
Our curriculum has maintained a 100% pass 
rate on the skills assessment and a a 94% pass 
rate on first attempt of the of the cognitive 
portion of the FLS exam with a 100% pass rate 
by second attempt. 
Access to Simulation Practice 
In order to facilitate practice, our residents have open 
access to: 
- Goldberg Surgical Skills Center which features two 
FLS trainer systems with ergonomic set up  
- Colodny Satellite Simulation Center (pictured on 
the right) with one FLS trainer system located right 
on Labor and Delivery 
Structured Practice 
FLS practice in our main surgical skills lab is built into 
the resident training curriculum: 
- Hour long sessions, 1 to 4 times each week during 1 
to 2 rotations in each of the first three years of 
residency 
- 2 hours of protected monthly simulation time with 
2 to 3 residents assigned to the skills lab over each 
hour 
- Residents make their way through tasks involving 
the FLS system and virtual reality trainers using a 
level appropriate checklist with tasks of increasing 
difficulty (i.e. off axis operator position, inverted 
camera) 
Feedback 
•Structured training sessions include real-time 
feedback from either our surgical skills lab specialist, 
or an appropriate attending 
•Feedback on progress is built into resident evals 
Operating Room Cases 
Residents work towards taking a primary role in OR 
laparoscopic cases based on skill level: 
- PGY3s teach PGY1s basic surgeries 
- PGY4s teach PGY2s advanced surgeries 
- Sim lab practice prior to cases is encouraged 
FLS Certification Requirements 
1. Web based education modules 
2. Hands on skills training 
3. FLS Test: two part assessment tool, evaluation of 
cognitive and technical skills 
Our residents work towards proficiency times 
on each technical skills task during simulation 
practice prior to exam day. 
PGY1: Primary & Preventative Care, Gyn/ Gyn 
Basics 
PGY2: Critical Care & Critical Thinking (CCCT), 
Elective 
PGY3: Minimally Invasive Medicine & Surgery 
(MIMS), Elective 
 
Completion of online FLS modules to prepare 
for the cognitive exam is done during these 
rotations. 
 
At the start of the 2018 academic year, our FLS 
certification requirement was moved up to 
from PGY3 to PGY2 year. 
Task FLS Proficiency 
Time 
Mean # of Attempts to 
Proficiency 
Peg Transfer 48 Seconds 8.45 
Precision Cutting 98 Seconds 4.58 
Endoloop 53 Seconds 3.75 
Extracorporeal Knot 
Tying 
136 Seconds 4.46 
Intracorporeal Knot 
Tying 
112 Seconds 4.69 
This analysis highlights a strong curriculum, 
which has been successfully incorporated into 
our Ob/Gyn program at UMMS- Baystate. We 
present this information as a blueprint for 
other programs to follow and/or modify in the 
setting of the new ABOG requirements for FLS 
certification.  
 
While our cognitive pass rate is also high, 
performance is limited by inclusion of 
questions about instruments and techniques 
not utilized by the average OB/Gyn 
practitioner. We hope that our educational 
leaders work towards production of a more 
appropriate cognitive assessment tool.  
